EUVIMEDOpdag EUVIMED
Crossref

Longitudinal peanut and Ara h 2 specific‐IgE , ‐ IgG 4 , and ‐ IgG 4 /‐ IgE ratios are associated with the natural resolution of peanut allergy in childhood

Kayla M Parker iD, Thanh D Dang iD, Rushani Wijesuriya iD, Victoria X Soriano iD, Adrian J Lowe iD, Shyamali C Dharmage iD, Paxton Loke iD, Mimi L K Tang iD, Katie J Allen iD, Jennifer J Koplin iD, Kirsten P Perrett iD, Rachel L Peters iD

Allergy · 2024

DOI: 10.1111/all.16111 ↗

At a glance

Journal article in Allergy, 2024. Written by Kayla M Parker and 11 co-authors. Institution: Murdoch Children's Research Institute, Parkville, Victoria, Australia. Major MEDLINE topics: Peanut Hypersensitivity, Immunoglobulin E, Antigens, Plant, 2S Albumins, Plant. Cited 24 times so far (Crossref); 56 references. Funded by: Elizabeth & Vernon Puzey Foundation, Australian Government Research Training Program.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

There are no studies of longitudinal immunoglobulin measurements in a population‐based cohort alongside challenge‐confirmed peanut allergy outcomes. Little is known about biomarkers for identifying naturally resolving peanut allergy during childhood.

Objectives

To measure longitudinal trends in whole peanut and component Ara h 2 sIgE and sIgG 4 in the first 10 years of life, in a population cohort of children with challenge‐confirmed peanut allergy, and to determine whether peanut‐specific immunoglobulin levels or trends are associated with peanut allergy persistence or resolution by 10 years of age.

Methods

One‐year‐old infants with challenge‐confirmed peanut allergy ( n = 156) from the HealthNuts study ( n = 5276) were prospectively followed at ages 4, 6, and 10 years with questionnaires, skin prick tests, oral food challenges, and plasma total‐IgE, sIgE and sIgG 4 to peanut and Ara h 2.

Results

Peanut allergy resolved in 33.9% (95% CI = 25.3%, 43.3%) of children by 10 years old with most resolving (97.4%, 95% CI = 86.5%, 99.9%) by 6 years old. Decreasing Ara h 2 sIgE ( p = .01) and increasing peanut sIgG 4 ( p < .001), Ara h 2 sIgG 4 ( p = .01), peanut sIgG 4 /sIgE ( p < .001) and Ara h 2 sIgG 4 /sIgE ( p < .001) from 1 to 10 years of age were associated with peanut allergy resolution. Peanut sIgE measured at 1 year old had the greatest prognostic value (AUC = 0.75 [95% CI = 0.66, 0.82]); however, no single threshold produced both high sensitivity and specificity.

Conclusion

One third of infant peanut allergy resolved by 10 years of age. Decreasing sIgE and sIgG 4 to peanut and Ara h 2 over time were associated with natural resolution of peanut allergy. However, biomarker levels at diagnosis were not strongly associated with the natural history of peanut allergy.

Subjects

MeSH terms (MEDLINE)

Peanut HypersensitivityImmunoglobulin EAntigens, Plant2S Albumins, PlantArachisImmunoglobulin GHumansMaleChildFemaleChild, PreschoolInfantBiomarkersLongitudinal StudiesAllergensGlycoproteinsSkin Tests

Author keywords

Ara h 2IgEIgG4peanutresolution

Substances

Immunoglobulin EAntigens, Plant2S Albumins, PlantImmunoglobulin GAra h 2 allergen, Arachis hypogaeaBiomarkersAllergensGlycoproteins

Authors and institutions

  • Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia.
  • Melbourne School of Population and Global Health, University of Melbourne, Parkville, Victoria, Australia.
  • Monash Children's Hospital, Monash Health, Clayton, Victoria, Australia.
  • Department of Allergy and Immunology, Royal Children's Hospital, Parkville, Victoria, Australia.
  • Child Health Research Centre, University of Queensland, Brisbane, Queensland, Australia.

ORCID profiles: Kayla M Parker, Thanh D Dang, Rushani Wijesuriya, Victoria X Soriano, Adrian J Lowe, Shyamali C Dharmage, Paxton Loke, Mimi L K Tang, Katie J Allen, Jennifer J Koplin, Kirsten P Perrett, Rachel L Peters

Funding

  • Elizabeth & Vernon Puzey Foundation
  • Australian Government Research Training Program

Cite

APA

Parker, K. M., Dang, T. D., Wijesuriya, R., Soriano, V. X., Lowe, A. J., Dharmage, S. C., Loke, P., Tang, M. L. K., Allen, K. J., Koplin, J. J., Perrett, K. P., & Peters, R. L. (2024). Longitudinal peanut and Ara h 2 specific‐IgE , ‐ IgG 4 , and ‐ IgG 4 /‐ IgE ratios are associated with the natural resolution of peanut allergy in childhood. Allergy. https://doi.org/10.1111/all.16111

Vancouver

Parker KM, Dang TD, Wijesuriya R, Soriano VX, Lowe AJ, Dharmage SC, et al. Longitudinal peanut and Ara h 2 specific‐IgE , ‐ IgG 4 , and ‐ IgG 4 /‐ IgE ratios are associated with the natural resolution of peanut allergy in childhood. Allergy. 2024. doi:10.1111/all.16111

BibTeX
@article{Parker2024,
  author = {Parker, Kayla M and Dang, Thanh D and Wijesuriya, Rushani and Soriano, Victoria X and Lowe, Adrian J and Dharmage, Shyamali C and Loke, Paxton and Tang, Mimi L K and Allen, Katie J and Koplin, Jennifer J and Perrett, Kirsten P and Peters, Rachel L},
  title = {Longitudinal peanut and Ara h 2 specific‐IgE , ‐ IgG 4 , and ‐ IgG 4 /‐ IgE ratios are associated with the natural resolution of peanut allergy in childhood},
  journal = {Allergy},
  year = {2024},
  doi = {10.1111/all.16111}
}
Start for free →